23.5BW worth of new drug research based on glycomics

Published: 2005-08-05 07:00:00

Updated: 2005-08-05 07:00:00

The Korea Drug Research Association (KDRA) announced on July 28 that a new drug research project based on "Glycomics" had been assigned to manage through the agreement with the Ministry of Industry and Energy, which requires about 23.5 billion won of investment for 7 years from July 1, this year ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK